Target intelligence / Profile preview

E74-like ETS transcription factor 2 (ELF2)

Target
ELF2
Molecular classification
Transcription factor, ETS family
01

Overview

E74-like ETS transcription factor 2 (ELF2) is a member of the ETS family of transcription factors, also known as new Ets-related factor (NERF)[1][3][5][7]. In humans, ELF2 is encoded by the ELF2 gene and is expressed as distinct isoforms (notably ELF2A and ELF2B) due to alternative promoter usage[2][4][5][6]. ELF2 isoforms regulate a wide range of genes critical for cell proliferation, cell cycle progression, hematopoietic differentiation, apoptosis, and angiogenesis[2][4][5][6]. ELF2A mainly acts as a transcriptional activator, while ELF2B functions as a repressor and can induce apoptosis and inhibit cell proliferation in certain contexts[2][4][6]. ELF2 plays a prominent role in early B and T cell development. Dysregulation of ELF2 has been linked to oncogenesis and progression of certain cancers, with evidence suggesting roles as both tumor suppressor and promoter depending on isoform and cellular context[2][4][6]. No small molecule or biologic drugs specifically targeting ELF2 or its downstream pathways have been reported, and ELF2 is not commonly classified as a canonical therapeutic target (such as a receptor, enzyme, transporter, etc.)[1][8][7].

Other names
NERFNERF-1ANERF-1BEU32new Ets-related factor
02

Biological functions

Transcriptional regulationCell cycle progressionApoptosisAngiogenesisHematopoietic lineage commitmentCell proliferationEarly B and T cell developmentGene expression regulation
03

Disease associations

CancerTumorigenesisHematologic malignanciesOther

Beyond the preview

Go deeper on E74-like ETS transcription factor 2 (ELF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E74-like ETS transcription factor 2 (ELF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call